Turley James S 4

What Happened James S. Turley, a director of Precigen, received an equity award on March 10, 2026. The filing shows 17,806 shares were issued to him at $3.51 per share (total reported value $62,499) issued in lieu of his $62,500 annual retainer. In addition, Turley was granted 35,612 RSUs and 41,073 RSUs (total 76,685 RSUs) as derivative awards (reported with $0 immediate cash value).

Key Details

• Transaction date: March 10, 2026; Form 4 filed March 12, 2026 (within the usual two-business-day window).
• Grant/award code: A (award/grant).
• Shares issued: 17,806 common shares @ $3.51 — reported total $62,499.
• Derivative awards: 35,612 RSUs and 41,073 RSUs (76,685 RSUs total) reported at $0 (contingent).
• RSU terms: Each RSU represents a contingent right to one share; RSUs vest in full on March 10, 2027 (per footnote).
• Shares owned after transaction: Not specified in the filing.
• Footnotes: F1 = shares issued in lieu of $62,500 annual retainer; F2 = RSU = contingent right to one share; F3 = RSUs vest in full on March 10, 2027.

Context These transactions are compensation-related awards rather than an open-market purchase or sale. The delivered shares reflect payment of an annual retainer; the RSUs are contingent and vest a year later, so they do not represent immediately tradable shares. Such grants are routine for directors and should be interpreted as compensation rather than a direct bullish or bearish trading signal.